Unforeseen chronic active brain inflammation, and widespread persistence of transgenic HSV1-TK, in long term survivors of adenovirus-mediated tumour eradication of syngeneic gliomas; implications for clinical trials.

P. R. LÖWENSTEIN; R. A. DEWEY; G. MORRISSEY; F BOLOGNANI; NJF DODD; D. KLATZMANN; T. D. SOUTHGATE; M. G. CASTRO

Washington, DC, USA

Congreso; 2nd Annual meeting of the American Society of Gene Therapy; 1999

No disponible